Training activity information
Details
Interpret haematological assays to inform testing strategies, to include:
- CLL
- Plasma cell dyscrasias
- Lymphoma
- MDS
Type
Entrustable training activity (ETA)
Evidence requirements
Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion.
Reflection at multiple timepoints on the trainee learning journey for this activity.
Considerations
Considerations are suggestions about what may be useful for the trainee to think about while undertaking a training activity. They should not be considered as a mandatory checklist. Trainees should not be expected to demonstrate or provide evidence for each of the considerations listed.
- Clinical presentation features
- Correlation with full blood counts, morphology, immunophenotyping, and histopathology
- Limitations and comparison of methodologies
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 1 |
Outcome
Identify the main clinical, morphological and phenotypical features of CLL, plasma cell dyscrasias, B cell lymphomas (low and high grade) and MDS. |
| # 2 |
Outcome
Select the relevant testing strategy for commonly referred haematological. |